Previous 10 | Next 10 |
HOUSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consume...
Guardion Health Sciences ( NASDAQ: GHSI ) on Tuesday said it regained compliance with Nasdaq's rule of $1 minimum bid price requirement for continued listing on the exchange. GHSI was previously notified by Nasdaq on Jan.25, 2022 that it was not in compliance with the minimum...
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that it has regained compliance with the mi...
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will effect a 1-for-50 reverse split of its common stock effective as of 4:01 p.m. Eastern Time on January 6, 2023. Commencing...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article focuses on penny stocks with “buy” ratings from analysts. Analysts have access to information about companies that retail investors cannot obtain. Consequently, analysts’ opinions o...
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that offers a portfolio of science-based, clinically supported products designed to support the health needs of co...
Guardion Health Sciences press release ( NASDAQ: GHSI ): Q3 GAAP EPS of -$0.11 misses by $0.08 . Revenue of $2.66M (-15.6% Y/Y) misses by $0.89M . As of September 30, 2022, the Company had cash and cash equivalents of $12.94M For further details see: ...
Viactiv® Generated Net Revenues of Approximately $2.6 Million or 96% of Net Revenues for the Quarter Ended September 30, 2022 Company Announces Program to Evaluate Strategic Alternatives HOUSTON, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq...
New Viactiv Omega Boost™ Gel Bites Clinically Proven to Increase Omega-3 Levels by 51% in Just 4 Weeks First-Ever Clinically Proven Gel Bites, with a Tasty Fruit Flavor and No Fish Burps, are a Proven Alternative to Swallowing Large Fish Oil Pills HOUSTON, Oct. 06, 20...
Guardion Health Sciences press release ( NASDAQ: GHSI ): Q2 GAAP EPS of -$0.03 beats by $0.01 . Revenue of $3.27M (+168.0% Y/Y) beats by $0.67M . Shares +5.3% PM For further details see: Guardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, ...
News, Short Squeeze, Breakout and More Instantly...
Guardion Health Sciences Inc. Company Name:
GHSI Stock Symbol:
NYSE Market:
Guardion Health Sciences Inc. Website:
2024-07-21 23:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-11 20:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of co...